Latest Videos |view all videos
Mayo Clinic’s medical oncologists and urologists discuss their multidisciplinary approach to the treatment of various genitourinary cancers.
Igor Frank, M.D., discusses surgical treatment options for patients with prostate cancer.
Landon Trost, M.D., Assistant Professor of Urology and current Head of Andrology and Male Infertility, Mayo Clinic, Rochester, Minnesota discusses Pyronies Disease therapies.
Landon Trost, M.D., Assistant Professor of Urology and current Head of Andrology and Male Infertility, Mayo Clinic, Rochester, Minnesota discusses therapies for non-psychogenic erectile dysfunction.
R. Jeffrey Karnes, M.D., Consultant and Associate Professor, Mayo Clinic, discusses treatment options for bladder cancer. The ailment can be subdivided into sub categories and the treatments dramatically differ. Invasive treatments can ...
Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors.
Low T - Health Risks of Testosterone Therapy - Mayo Clinic. Dr. William Young.
Researchers say the discovery of how sodium ions pass through the gill of a zebrafish may be a clue to understanding a key function in the human kidney. The findings from a collaboration between Mayo Clinic and the Tokyo Institute of Technology ...
A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk for poorer survival rate following prostate cancer treatment compared to other minority groups.